Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
rhBMP-2 in children with congenital tibial pseudarthrosis
2007-003835-22Phase 3Active
- Sponsor
- Hospices Civils de Lyon
- Start
- Aug 2007
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of dibotermin alfa in congenital pseudarthrosis of the tibia (CPT), sponsored by Hospices Civils de Lyon. Started Aug 2007; status: active.
02
Drugs
dibotermin alfa
03
Conditions
congenital pseudarthrosis of the tibia (CPT)
Beyond the preview
Go deeper on 2007-003835-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-003835-22.